Al Hammadi Company for Development and Investment reported a net profit of SAR 107.96 million for fiscal year 2017, a 47.97 percent year-on-year (YoY) increase.
The company said the increase in net profit is attributable to a 17 percent rise in revenue due to higher numbers of patients and optimized contractual terms with customers.
The company posted a net profit of SAR 30.76 million in the fourth quarter of 2017.
Q4 2017
2017
Period | healthy services and other | Pharmaceutical sales revenue - Pharmacies |
---|---|---|
Q1 2017 | 150.74 | 29.49 |
Q2 2017 | 147.45 | 29.26 |
Q3 2017 | 136.70 | 26.31 |
Q4 2017 | 155.95 | 32.73 |
Period | healthy services and other | Pharmaceutical sales revenue - Pharmacies |
---|---|---|
2010 | 224.05 | 77.50 |
2011 | 244.33 | 86.33 |
2012 | 274.90 | 103.78 |
2013 | 317.00 | 117.11 |
2014 | 360.30 | 121.61 |
2015 | 451.60 | 109.71 |
2016 | 552.40 | 89.11 |
2017 | 590.84 | 117.78 |
Item | Q4 2017 (e) | Q4 2017 (a) | Change |
---|---|---|---|
Average | 27.89 | 30.76 | 10.29 % |
Item | Q4 2017 (e) | Q4 2017 (a) | Change |
---|---|---|---|
Sico | 30.00 | 30.76 | 2.5 % |
Alistithmar Capital | 29.20 | 30.76 | 5.3 % |
AlJazira Capital | 29.20 | 30.76 | 5.3 % |
Al Rajhi Capital | 28.00 | 30.76 | 9.8 % |
OSOOL AND BAKHEET | 27.50 | 30.76 | 11.8 % |
SNB Capital | 27.00 | 30.76 | 13.9 % |
Arbah Capital | 26.20 | 30.76 | 17.4 % |
Albilad Capital | 26.00 | 30.76 | 18.3 % |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}